GPER1 and neuroendocrine neoplasm: Although GPER expression may serve as a prognostic marker in BP-NEN, the overall expression levels of GPER in neuroendocrine tumours are generally too low to be of clinical relevance, except in individual cases, particularly for pancreatic neoplasms.